Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)

NCT00399893 ·Status: TERMINATED ·Phase: NA

Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

NCT00174408 ·Status: COMPLETED ·Phase: PHASE3

Genotropin Treatment In Very Young Children Born Small For Gestational Age

NCT00627523 ·Status: COMPLETED ·Phase: PHASE3

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

NCT01073605 ·Status: COMPLETED ·Phase: PHASE3

Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

NCT04697381 ·Status: COMPLETED ·Phase: PHASE3

Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell

NCT02205450 ·Status: COMPLETED

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

NCT02616562 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

NCT07226089 ·Status: RECRUITING ·Phase: PHASE3

Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

NCT01604395 ·Status: RECRUITING

Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome

NCT00372125 ·Status: COMPLETED ·Phase: NA

A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA

NCT03221933 ·Status: COMPLETED ·Phase: PHASE2

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

NCT04798690 ·Status: RECRUITING

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

NCT02375620 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature

NCT03221088 ·Status: UNKNOWN ·Phase: PHASE2

Growth Hormone Study in Adults With Prader-Willi Syndrome

NCT04484051 ·Status: NOT_YET_RECRUITING

Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.

NCT00522743 ·Status: COMPLETED ·Phase: NA

GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition

NCT03616509 ·Status: COMPLETED ·Phase: PHASE4

A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome

NCT03189160 ·Status: UNKNOWN ·Phase: PHASE2

Ghrelin Suppression by Octreotide in Prader-Willi

NCT01613495 ·Status: UNKNOWN ·Phase: NA

Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age

NCT00174460 ·Status: COMPLETED ·Phase: PHASE2

Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children

NCT01342146 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

NCT01502124 ·Status: COMPLETED ·Phase: PHASE3

Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia

NCT00140413 ·Status: COMPLETED ·Phase: PHASE4

Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

NCT00837863 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)

NCT03245333 ·Status: UNKNOWN ·Phase: PHASE3